Skip to main content
. 2020 Feb 11;2020(2):CD004863. doi: 10.1002/14651858.CD004863.pub6

3.5. Analysis.

3.5

Comparison 3 Darbepoetin alfa or erythropoietin (erythropoiesis‐stimulating agents ‐ ESAs) versus placebo or no treatment, Outcome 5 BASC‐2 composite scores at 3.5 to 4 years ‐ adaptive skills.